metabolic and endocrine function

152
Metabolic and Endocrine Function Larry Santiago, MSN, RN

Upload: clove

Post on 27-Jan-2016

44 views

Category:

Documents


0 download

DESCRIPTION

Metabolic and Endocrine Function. Larry Santiago, MSN, RN. Assessment and Management of Patients With Hepatic Disorders. Assessment. Health History Exposure to hepatotoxins Alcohol and drug use Lifestyle behaviors Physical Examination Skin inspection Abdominal assessment Liver palpation. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Metabolic and Endocrine Function

Metabolic and Endocrine Function

Larry Santiago, MSN, RN

Page 2: Metabolic and Endocrine Function
Page 3: Metabolic and Endocrine Function

Assessment and Management of Patients With Hepatic

Disorders

Page 4: Metabolic and Endocrine Function

Assessment

• Health History–Exposure to hepatotoxins–Alcohol and drug use–Lifestyle behaviors

• Physical Examination–Skin inspection–Abdominal assessment–Liver palpation

Page 5: Metabolic and Endocrine Function

Diagnostic Evaluation

• Liver Function Tests – page 1079• Liver Biopsy-removal of a small amount of liver tissue through needle aspiration

Page 6: Metabolic and Endocrine Function

Diagnostic Evaluation 2

–Ultrasonography

–Computed

Tomography

Page 7: Metabolic and Endocrine Function

Diagnostic Evaluation 3

- Magnetic resonance imaging (MRI)

- Laparoscopy

Page 8: Metabolic and Endocrine Function

Hepatic Dysfunction

• Jaundice- hemolytic, hepatocellular, obstructive, and hereditary hyperbilirubinemia

Page 9: Metabolic and Endocrine Function

Hepatic Dysfunction 2

• Portal Hypertension

• Ascites

Page 10: Metabolic and Endocrine Function
Page 11: Metabolic and Endocrine Function

Ascites

• Pathophysiology

• Clinical manifestations

Page 12: Metabolic and Endocrine Function

Ascites 2

• Medical/Nursing management

- Dietary Modification – strict sodium restriction

- Diuretics

Page 13: Metabolic and Endocrine Function

Ascites 3

- Bed Rest

- Paracentesis

Page 14: Metabolic and Endocrine Function

Esophageal Varices

• - dilated, tortuous veins found in the submucosa of the esophagus or even the stomach

Page 15: Metabolic and Endocrine Function

Hepatic Encephalopathy and Coma

• Results from accumulation of ammonia and other toxic metabolites in the blood

• Hepatic coma represents most advanced stage of hepatic encephalopathy

• Clinical manifestations include: mental changes, motor disturbances, asterixis and constructional apraxia

Page 16: Metabolic and Endocrine Function

Hepatic Encephalopathy

- RN is responsible for maintaining a safe environment to prevent injury, bleeding, and infection

- Assess neuro status frequently

- Strict I & O

- Assess for symptoms of infection

- Monitor serum ammonia level and electrolytes

Page 17: Metabolic and Endocrine Function

Management of Patients With Viral Hepatic Disorders

• Viral Hepatitis

- Systemic viral infection in which necrosis and inflammation of the liver cells produce a cluster of changes

- Includes Hepatitis A,B,C,D, and E

Page 18: Metabolic and Endocrine Function

Hepatitis A

• Mode of transmission

- fecal/oral

Signs & Symptoms:

Headache, malaise,

fatigue, later on dark

urine, jaundice, tender

liver

Page 19: Metabolic and Endocrine Function
Page 20: Metabolic and Endocrine Function

Hepatitis B

• Mode of transmission:

- sex, either by intercourse

or oral contact

- Perinatal tranmission

- Health care personnel

- Long incubation period (70-80 days)

- Signs/symptoms insidious and variable

Page 21: Metabolic and Endocrine Function

Hepatitis B 2

• Active Immunization: Hepatitis B Vaccine

• Passive Immunity: Hepatitis B Immune Globulin

Page 22: Metabolic and Endocrine Function

Hepatitis B 3

• Medical/Nursing management

- Antiviral agents – Epvir and Hepsera

- Bed rest, activity restriction

- Adequate nutrition

Page 23: Metabolic and Endocrine Function

Hepatitis C

• Mode of transmission:- Blood transfusion- Risk increased with STDSigns and Symptoms:Similar to HBV, but less severe and anicteric- Increased risk of chronic liver disease and

hepatic cancer- Hepatitis G risk factors similar to HCV

Page 24: Metabolic and Endocrine Function

Hepatitis D

• Mode of transmission:

- same as HBV

Signs and Symptoms:

Similar to HBV

Outcome:

Greater likelihood of carrier state, chronic active hepatitis, and cirrhosis

Page 25: Metabolic and Endocrine Function
Page 26: Metabolic and Endocrine Function

Hepatitis E

Mode of transmission:Fecal-oralSigns and Symptoms:Similar to HAVVery severe in PG womenOutcome:Similar to HAV except very severe in PG

women

Page 27: Metabolic and Endocrine Function

Management of Patients With Nonviral Hepatic Disorders

• Toxic Hepatitis

- Exposure to

hepatotoxic chemicals or meds

- Symptoms include vomiting, abnormal clotting, delirium, coma, seizures, death

Page 28: Metabolic and Endocrine Function

Hepatic Cirrhosis

• Types of cirrhosis:

- Alcoholic cirrhosis – most common

- Postnecrotic cirrhosis – broad bands of scar tissue from previous acute viral hepatitis

- Biliary cirrhosis – result of chronic biliary obstruction and infection – much less common

Page 29: Metabolic and Endocrine Function

Hepatic Cirrhosis 2

• Pathophysiology

- Alcohol consumption major

causative factor

- Characterized by episodes

of necrosis involving the liver cells

- Destroyed liver cells are replaced by scar tissue

Page 30: Metabolic and Endocrine Function

Hepatic Cirrhosis 3

• Clinical manifestations- Hepatomegaly- Portal Obstruction and Ascites- Infection and Peritonitis- Gastrointestinal varices- Edema- Vitamin deficiency and anemia- Mental deterioration

Page 31: Metabolic and Endocrine Function

Hepatic Cirrhosis 4

• Assessment and Diagnostic Findings

• Medical Management

Page 32: Metabolic and Endocrine Function

Assessment and Management of Patients With Biliary Disorders

Page 33: Metabolic and Endocrine Function
Page 34: Metabolic and Endocrine Function

Diseases of the Gallbladder

• Cholecystitis- acute inflammation, calculous cholecystitis

• Cholelithiasis-

gallstones

Page 35: Metabolic and Endocrine Function

Cholelithiasis

• Medical Management- lithotripsy, UDCA and CDCA, MTBE, ERCP

Page 36: Metabolic and Endocrine Function

• ERCP

Page 37: Metabolic and Endocrine Function

Cholelithiasis 2

• Surgical Management- cholecystectomy

Page 38: Metabolic and Endocrine Function
Page 39: Metabolic and Endocrine Function

Cholelithiasis 3

• Nursing Management- relieve pain, promote biliary drainage, improve nutritional status

Page 40: Metabolic and Endocrine Function

Diseases of the Pancreas

• Acute Pancreatitis- mild, self- limiting to fatal, self-digestion of pancreas by proteolytic enzymes

Page 41: Metabolic and Endocrine Function

Acute Pancreatitis

Gerontologic considerations – mortality increases with advancing age

Page 42: Metabolic and Endocrine Function

Acute Pancreatitis 2

• Pathophysiology

- Caused by self-digestion of the pancreas

- Long-term use of alcohol is commonly associated

- Mortality rate is high (10%)

Page 43: Metabolic and Endocrine Function

Acute Pancreatitis 3

• Clinical Manifestations

- Severe abdominal pain

- Nausea/vomiting

- Hypotension

- Respiratory distress

- Tachycardia

- Cyanosis

Page 44: Metabolic and Endocrine Function

Acute Pancreatitis 4

• Medical Management directed at relief of symptoms, prevention and treatment of complications, and managing exocrine and endocrine insufficiency of pancreatitis

Page 45: Metabolic and Endocrine Function

Chronic Pancreatitis

- Characterized by progressive anatomic and functional destruction of the pancreas

- End result is mechanical obstruction of the pancreatic and common bile ducts and the duodenum

- Major causes are alcoholism and malnutrition

Page 46: Metabolic and Endocrine Function

Chronic Pancreatitis 2

• Clinical Manifestations

- Recurring attacks of severe abdominal and back pain

- Vomiting

- Opioids often do not provide relief

- Weight loss

- Steatorrhea

Page 47: Metabolic and Endocrine Function

Chronic Pancreatitis 3

• Medical Management

- Pain management

- Diabetes Mellitus

- Pancreatico-

jejunostomy

Page 48: Metabolic and Endocrine Function
Page 49: Metabolic and Endocrine Function

• Assessment and Management of Patients With Diabetes Mellitus

Page 50: Metabolic and Endocrine Function

Diabetes Mellitus

• Type 1- destruction of pancreatic beta cells

- Combined genetic, immunologic, and environmental factors contribute to beta cell destruction

Page 51: Metabolic and Endocrine Function

Diabetes Mellitus 2

• Type 2- insulin resistance and impaired insulin secretion

Page 52: Metabolic and Endocrine Function

Diabetes Mellitus 2

• Gestational Diabetes- glucose intolerance with onset during pregnancy

Page 53: Metabolic and Endocrine Function
Page 54: Metabolic and Endocrine Function

Assessment and Diagnostic Findings

• 3 P’s- polyuria, polydipsia, polyphagia

Page 55: Metabolic and Endocrine Function

Assessment and Diagnostic Findings 2

• Fasting Plasma Glucose > 126 mg/dL

• Random Plasma Glucose > 200 mg/dL

• 2-hour Postload Glucose > 200 mg/dL

Page 56: Metabolic and Endocrine Function

Diabetes Management

Page 57: Metabolic and Endocrine Function

Diabetes Management

• Complications- retinopathy, nephropathy, and neuropathy

Page 58: Metabolic and Endocrine Function

Diabetes Management 2

• Hypoglycemia

Page 59: Metabolic and Endocrine Function

Nutrition

• Nutrition, diet, and weight control are the foundation of diabetes management

• Meal Planning and Related Teaching

Page 60: Metabolic and Endocrine Function

Meal Planning• Caloric Requirements- To promote a 1-2 lb.

weight loss per week, 500

to 1,000 calories are

subtracted from the daily

total

Page 61: Metabolic and Endocrine Function

Caloric Distribution

• Carbohydrates

• Fats

• Fiber

Page 62: Metabolic and Endocrine Function

Exercise

• Benefits

• Exercise precautions

• Exercise recommendations

• Gerontologic considerations

Page 63: Metabolic and Endocrine Function

Monitoring Glucose Levels

Glycosated Hemoglobin – HgbA1c

- Reflects average blood glucose levels over 2-3 months

Page 64: Metabolic and Endocrine Function

Pharmacologic Therapy

• Insulin Therapy and Insulin Preparations

- Grouped into several categories based on the onset, peak,

and duration of action

Page 65: Metabolic and Endocrine Function

Categories of Insulin

• Rapid actingAgent – Lispro (Humalog) - Aspart (Novolog)Onset – 10-15minPeak – 1 hour - 40-50min (Aspart)Duration – 3 hours - 4-6 hours (Aspart)

Page 66: Metabolic and Endocrine Function

Categories of Insulin 2

• Short-acting

• Agent – Regular (Humalog R, Novolin R)

• Onset – ½ - 1 hour

• Peak – 2-3 hours

• Duration – 4-6 hours

Page 67: Metabolic and Endocrine Function

Categories of Insulin 3

• Intermediate-acting

- NPH

- Humulin N, Novolin N

Onset – 3-4 hours

Peak – 6-12 hours

Duration – 16-20 hours

Page 68: Metabolic and Endocrine Function

Categories of Insulin 4

• Long-acting

• Agent

- Ultralente

Onset – 6-8 hours

Peak – 12-16 hours

Duration – 20-30 hours

Page 69: Metabolic and Endocrine Function

Categories of Insulin 5

• Very long-acting

Agent – Lantus

Onset – 1 hour

Peak – Continuous

Duration – 24 hours

Indications – Used primarily to control fasting glucose level

Page 70: Metabolic and Endocrine Function

Insulin Regimens• Conventional Regimen- One or more injections of a

mixture of short and intermediate acting insulins per day

- Patients may have blood glucose levels well above normal

Page 71: Metabolic and Endocrine Function

Insulin Regimens 2

• Intensive Regimen

- Keeps blood glucose

Levels as close to normal

as possible

Example – Insulin Sliding

Scale

Page 72: Metabolic and Endocrine Function

Complications of Insulin Therapy

• Complications- allergic reactions, lipodystrophy, resistance, hyperglycemia

Page 73: Metabolic and Endocrine Function

Methods of DeliveryInsulin pens –

Jet injectors –

Insulin pumps -

Page 74: Metabolic and Endocrine Function

Oral Antidiabetic Agents1) Sulfonylureas

- Directly stimulate the pancreas to secrete insulin

- Side effects – GI symptoms and dermatologic reactions

2) Biguanides

- Facilitates insulin’s action on

peripheral receptor sites

Page 75: Metabolic and Endocrine Function

Oral Antidiabetic Agents 2

• Thiazolidinediones

- Enhance insulin action at the receptor site

without increasing insulin secretion from the beta cells of the pancreas

- May affect liver function

Page 76: Metabolic and Endocrine Function

Oral Antidiabetic Agents 3

• Meglitinides

- Lowers blood glucose level by stimulating insulin release from the pancreatic beta cells

- Principal side effect is hypoglycemia

Page 77: Metabolic and Endocrine Function
Page 78: Metabolic and Endocrine Function

Nursing Management

• Diabetic Teaching Plan

- Self-Administration of Insulin

Storing Insulin

Selecting Syringes

Page 79: Metabolic and Endocrine Function

Nursing Management 2

• Preparing the Injection: Mixing Insulins

• Selecting and Rotating the Injection Site

Page 80: Metabolic and Endocrine Function

Acute Complications• HypoglyemiaClinical Manifestations- Mild hypoglycemia – sweating, tremor,

tachycardia, palpitations, nervousness, hunger

- Moderate – inability to concentrate, headache, lightheadedness, confusion, memory lapses, numbness of lips and tonuge

Page 81: Metabolic and Endocrine Function

Hypoglycemia 2

• Severe hypoglycemia

Clinical manifestations – disoriented behavior, seizures, difficulty arousing from sleep, loss of consciousness

Page 83: Metabolic and Endocrine Function

Emergency Measures

• Patients who are unconscious or cannot swallow

- 25-50 mL 50% Dextrose in Water (D50W) administered IV

- Effect usually seen within minutes

Page 84: Metabolic and Endocrine Function

Diabetic Ketoacidosis• 3 Main Features:

1) Hyperglycemia

2) Dehydration and

electrolyte loss

3) Acidosis

Page 85: Metabolic and Endocrine Function

Pathophysiology

• 3 Main Causes

- Decreased or missed dose of insulin

- Illness or infection

- Undiagnosed and

untreated diabetes

Page 86: Metabolic and Endocrine Function

Diabetic Ketoacidosis 2

• Clinical manifestations – Polyuria, polydipsia, blurred vision, headache, anorexia, nausea, vomiting, abdominal pain, acetone or “fruity” breath, hyperventilation (Kussmaul respirations)

• Diagnostic Findings

Blood glucose levels vary from 300-800 mg/dL

Page 87: Metabolic and Endocrine Function

Diabetic Ketoacidosis 3

• Prevention

- Patients must be taught “sick day” rules:

Do not eleminate insulin when nausea/vomiting occurs

If patients cannot take fluids without

vomiting, the MD must be

notified

Page 88: Metabolic and Endocrine Function

Diabetic Ketoacidosis 4

• Medical/Nursing management

- Rehydration

- Restoring Electrolytes

- Reversing Acidosis

- Monitor EKG

- Patient Teaching

Page 89: Metabolic and Endocrine Function

HHMS

• Hyperglycemic Hyperosmolar Nonketotic Syndrome

- Serious condition with alterations of the sensorium

- Ketosis is minimal or absent

- Occurs most often in older people with no history of DM or mild Type 2 DM

Page 90: Metabolic and Endocrine Function

HHMS 2

• Clinical manifestations

- Hypotension, profound dehydration, tachycardia, variable neurologic signs (coma, seizures, hemiparesis)

- Mortality rate – 10-40%

Page 91: Metabolic and Endocrine Function

HHMS 3

• Assessment and Diagnostic Findings

- Blood glucose level 600-1200 mg/dL

- Electrolyte levels consistent with dehydration

- Mental status changes

- Hallucinations

- Postural hypotension

Page 92: Metabolic and Endocrine Function

HHMS 4

• Medical Management

- Fluid replacement

- Correction of electrolyte imbalances

- Insulin administration

Page 93: Metabolic and Endocrine Function

Long-Term Complications

• Macrovascular Complications- MI, CAD, Stroke

Page 94: Metabolic and Endocrine Function

Long-Term Complications 2

• Microvascular Complications and Diabetic Retinopathy

- Leading cause of blindness between 20-74 years old

- Most diabetics have some degree of retinopathy after 20 years (especially Type 1 diabetics)

Page 95: Metabolic and Endocrine Function

Long-Term Complications 3

• Retinopathy – Deterioration of small blood vessels that nourish the retina

Page 96: Metabolic and Endocrine Function

Long Term Complications 4

• Cataracts – Opacity of the lens of the eye; cataracts occur at an earlier age in diabetics

Page 97: Metabolic and Endocrine Function

Long Term Complications 5

• Glaucoma

- Results from occlusion of the outflow channels by new blood vessels. May occur with slightly higher frequency in the diabetic population

Page 98: Metabolic and Endocrine Function
Page 99: Metabolic and Endocrine Function

Nephropathy

• 20-30% of people with Type 1 or Type 2 diabetes develop nephropathy

Page 100: Metabolic and Endocrine Function

Nephropathy 2

• Assessment and diagostic findings

- Urine dipstick test consistently positive for significant amounts of albumin

- Serum creatinine and BUN

Page 101: Metabolic and Endocrine Function

Nephropathy 3

• Medical Management

- Control of Hypertension

- Prevention or vigorous treatment of UTI

- Avoidance of nephrotoxic substances

- Adjustment of meds as renal function changes

- Low sodium, low protein diet

Page 102: Metabolic and Endocrine Function

Diabetic Neuropathy

• Peripheral

- Symptoms include paresthesias and burning sensations

- Decreased pain and temperature sensation

- Foot deformities

- Lower extremity pain

Page 103: Metabolic and Endocrine Function

Peripheral Neuropathy

• Management

- Intensive insulin therapy and good blood glucose control delays onset and slows progression

- Pain management

Page 104: Metabolic and Endocrine Function

Autonomic Neuropathy

• Hypoglycemic Unawareness

- Autonomic neuropathy of the adrenal medulla is responsible for diminished symptoms of hypoglycemia

• Sexual Dysfunction

- Impotence occurs with greater

frequency in diabetic men

Page 105: Metabolic and Endocrine Function

Foot and Leg Problems

• Neuropathy – Increased dryness and fissuring of the skin

• Peripheral Vascular Disease –

Poor circulation of the lower

extremities contributes to poor

wound healing/gangrene

• Immunocompromise – Impaired ability of leukocytes to destroy bacteria

Page 106: Metabolic and Endocrine Function

• Assessment and Management of Patients With Endocrine Disorders

Page 107: Metabolic and Endocrine Function
Page 108: Metabolic and Endocrine Function
Page 109: Metabolic and Endocrine Function

Pituitary Disorders

• Diabetes Insipidus- deficiency of antidiuretic hormone

- Clinical Manifestations –

Enormous daily output of

very dilute urine

Spec Grav 1.001-1.005

Page 110: Metabolic and Endocrine Function

Diabetes Insipidus

• Medical Management

- To replace ADH

- Ensure adequate fluid replacement

- Identify and correct the underlying intracranial pathology

Page 111: Metabolic and Endocrine Function

Diabetes Insipidus 2

• Pharmacologic Therapy

- DDAVP – synthetic

vasopresin without the

Vascular effects of natural

ADH

- Intranasal

- IM ADH

Page 112: Metabolic and Endocrine Function

Syndrome of Inappropriate Antidiuretic Hormone Secretion

SIADH – excessive growth hormone secretion from the pituitary gland

- Important to eliminate the underlying cause – example: lung CA

Page 113: Metabolic and Endocrine Function

Thyroid Disorders

HypothyroidismMyxedema – advancedthyroid deficiencyHashimoto’s Disease –AKA autoimmune thyroiditis is the most common cause of

hypothyroidism

Page 114: Metabolic and Endocrine Function

Hypothyroidism

• Pathophysiology

- >95% have primary or thyroidal hypothyroidism, which refers to dysfunction of the

thyroid gland itself

Page 115: Metabolic and Endocrine Function

Hypothyroidism 2

• Clinical Manifestations

- Extreme fatigue

- Hair loss, brittle nails, dry skin

Page 116: Metabolic and Endocrine Function

Hypothyroidism 3

• Affects women five times more frequently then men, occurs most often between 30-60 years old

• Low temperature and

pulse rate

- Weight gain, thickened

skin, personality changes

Page 117: Metabolic and Endocrine Function

Hypothyroidism 4

• Medical Management- Pharmacologic TherapySynthroid or Levothroid- Prevention of Medication Interactions- Gerontologic Considerations- Modifying Activity- Monitoring Physical Status- Promoting Physical Comfort

Page 118: Metabolic and Endocrine Function

Hyperthyroidism

• Second most common endocrine disorder after DM

Grave’s disease - most common type

- Results from an excessive output of thyroid hormones caused by abnormal stimulation of the thyroid gland

Page 119: Metabolic and Endocrine Function

Hyperthyroidism 2

• Clinical manifestations

- Nervousness

- Palpitations

- Poor heat tolerance, diaphoresis

- Elderly – dry skin and pruritis

- Exophthalmos

- Increased appetite

Page 120: Metabolic and Endocrine Function

Hyperthyroidism 4

• Diagnostic Findings – increase in serum T4

• Medical Management

- Pharmacologic therapy –

Use of irradiation by

administration of the

radioisotope 123I

Page 121: Metabolic and Endocrine Function

Hyperthyoidism 5

• Antithyroid medications

- Propacil or Tapazole

- Blocks the utilization of iodine

by interfering with the

Iodothyrosines in the synthesis of thyroid

hormones

Page 122: Metabolic and Endocrine Function

Thyroid Storm

• Form of severe hyperthyroidism

• Almost always fatal without treatment

• Critically ill and requires astute observation and aggressive care

Page 123: Metabolic and Endocrine Function

Thyroid Storm 2

• Clinical Manifestations

- High fever (above 101.3F)

- Extreme tachycardia (>130)

- Exaggerated hyperthryoid sx

- Delirium psychosis, coma

Page 124: Metabolic and Endocrine Function

Thyroid Storm 3

• Management- Hypothermia mattress or blanket- Humidified oxygen- IV fluids- PTU or methimazole- Hydrocortizone – treat shock/adrenal

insuffciency- Iodine – decrease output of T4 from the thyroid

gland

Page 125: Metabolic and Endocrine Function

Hyperthyroidism 6

• Surgical Management

- Reserved for special circumstances

Examples – PG with allergy to antithyroid meds, large goiters

- Subtotal thyroidectomy –

Removal of 5/6 of thyroid

tissue

Page 126: Metabolic and Endocrine Function

Thyroid Tumors

Endemic Goiter

- Most common type of goiter

- Encountered where natural

iodine supply is deficient

- Represents a compensatory hypertrophy of the thyroid gland

- Recedes after iodine imbalance is corrected

Page 127: Metabolic and Endocrine Function

Nodular Goiter

• Areas of hyperplasia

• Nodules can descend into the thorax and cause local pressure symptoms

• Can become malignant

Page 128: Metabolic and Endocrine Function

Thyroid Cancer

• Assessment and

Diagnostic Findings

- Lesions that are single,

hard, fixed on palpation

- Diagnose with needle

biopsy, MRI, CT,

Thyroid scan

Page 129: Metabolic and Endocrine Function

Thyroid Cancer 2

• Surgical Management- Total or near-total thyroidectomy- Thyroid hormone administered in suppressive doses after surgery- Radiation – oral administration of radioactive

iodine, external administration of radiation therapy

Page 130: Metabolic and Endocrine Function

Nursing Management

• Preoperative Care

- Diet high in carbohydrates and proteins

- Demonstrate raising the elbows and placing the hands behind the neck to provide support

Page 131: Metabolic and Endocrine Function

Nursing Management 2

• Postoperative Care

- Assess surgical dsg and reinforce PRN

- Monitor for respiratory distress

- Pain management

- IV fluids

- Discourage talking

- OOB same day

Page 132: Metabolic and Endocrine Function
Page 133: Metabolic and Endocrine Function

Parathyroid Disorders

• Parathyroid Function

- Regulates Calcium and

Phosphorus metabolism

- Increased secretion of parathormone results in increased calcium absorption from kidney, intestine, and bones

- Excess parathormone can result in elevated levels of serum calcium

Page 134: Metabolic and Endocrine Function

Hyperparathyroidism

• Caused by overproduction of parathyroid hormone by the parathyroid glands

• Occurs 2-4 times more often in women, common between 60-70 year old

Page 135: Metabolic and Endocrine Function

Hyperparathyroidism 2

• Clinical Manifestations

- May be asymptomatic

- Fatigue, muscle

weakness, nausea,

constipation cardiac dysrythmias – related to hypercalcemia

- Skeletal pain and tenderness, esp. back and joints; pathologic fx or deformities

Page 136: Metabolic and Endocrine Function

Hyperparathyroidism 3

• Assessment and Diagnostic Findings

- Diagnosed by persistent elevation of serum calcium levels and elevated parathormone level

- Double antibody parathyroid hormone test

- Ultrasound, MRI, thallium scan, fine-needle biopsy

Page 137: Metabolic and Endocrine Function

Hypercalcemic Crisis

• Serum calcium greater than 15 mg/dL

• Life-threatening! – neurologic,

cardiovascular, renal symptoms

Treatment: rehydration with

large amt. of IV fluids, diuretics

to excrete calcium, phosphate

supplements

Page 138: Metabolic and Endocrine Function

Hyperparathyroidism 4

• Medical Management

- Hydration Therapy

- Mobility

- Diet and Medications

- Important to follow up to ensure return of calcium levels to normal

Page 139: Metabolic and Endocrine Function

Hypoparathyroidism

• occurs frequently with thryoidectomy or radical

neck dissection

• Caused by a deficiency of parathormone that results in elevated blood phosphate

Page 140: Metabolic and Endocrine Function

Hypoparathyroidism 2

• Clinical manifestations- Chief symptom – TETANY(tremor and spasmodic or uncoordinated contractions occurring with or without efforts to make voluntary movements)- Broncho or laryngeal spasm, carpopedal spasm,

dysphagia, photophobia, dysrhythmias, seizures

Page 141: Metabolic and Endocrine Function

Hypoparathyroidism 3

• Assessment and Diagnostic Findings

- Tetany develops at calcium levels of 5-6 mg/dL

Trousseau’s sign – carpal spasms Chvostek’s sign – cheek twitching

Page 142: Metabolic and Endocrine Function

Hypoparathyroidism 4

• Medical Management

- Goal of therapy to raise serum calcium level to 9-10 mg/dL

- IV Calcium gluconate

- IV Parathormone

(high incidence of allergies)

- Environment free of noise, drafts, bright lights, or sudden movement

Page 143: Metabolic and Endocrine Function

Nursing Management

• Post-op thyroidectomy care

• Keep Calcium gluconate at bedside

• Watch for potentially fatal dysrhythmias

• Teach about high calcium and low phosphate intake

Page 144: Metabolic and Endocrine Function

Adrenal Disorders

• Addison’s disease AKA adrenocortical insufficiency

- Adrenal cortex function is inadequate to meet patient’s need for cortical hormones

- 80% of cases caused by autoimmunity or idiopathic

Page 145: Metabolic and Endocrine Function

Addison’s disease

• Clinical manifestations

- Characterized by muscle weakness, anorexia, GI symptoms, fatigue, emaciation, dark pigmentation, hypotension, hypoglycemia,

hyponatremia,

hyperkalemia

Page 146: Metabolic and Endocrine Function

Addisonian crisis

- Characterized by cyanosis and classic signs of circulatory shock:

Pallor, apprehension, rapid and weak pulse, rapid respirations, low BP, headache, nausea, abd pain, diarrhea

- Complication of Addison’s

disease

Page 147: Metabolic and Endocrine Function

Addison’s disease 2

• Diagnostic findings

- Low levels of adrenocortical hormones in the blood or urine

- Decreased cortisol levels

Page 148: Metabolic and Endocrine Function

Addison’s disease 3 – Medical managment

• Combating circulatory shock:

- Restoring blood circulation

- Administering fluids and corticosteroids

- IV Hydrocortisone

Page 149: Metabolic and Endocrine Function

Nursing Management

• Assessing the patient

• Monitoring and Managing Addisonian Crisis

• Restoring Fluid Balance

• Improving Activity Tolerance

Page 150: Metabolic and Endocrine Function

Cushing’s Syndrome

• Results from excessive adrenocortical activity

• Commonly caused by use of corticosteroid medications

• Also caused by overproduction of endogenous corticosteroids

Page 151: Metabolic and Endocrine Function

Clinical Manifestations

• Central-type obesity, with a fatty “buffalo hump” neck and supraclavicular areas, heavy trunk, and relatively thin extremities

• Skin is thin, fragile and easily traumatized• Ecchymosis and striae develop• Muscle wasting, osteoporosis• Moon faced appearance• Women 20-40 years are 5x more likely than men to get Cushing’s

Page 152: Metabolic and Endocrine Function

Medical Management

• If cause is pituitary tumors, surgical removal by transsphenoidal hypophysectomy

• Symptoms of adrenal insufficiency may begin 12-48 hours after surgery

• Hydrocortisone for temporary replacement

• Reduce or taper corticosteroids to the minimum dosage need to treat the disease